IRIS
PICARDI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.560
EU - Europa 3.091
AS - Asia 2.918
SA - Sud America 451
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 35.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.366
SG - Singapore 1.379
DE - Germania 867
CN - Cina 653
RU - Federazione Russa 405
UA - Ucraina 381
BR - Brasile 361
IT - Italia 318
IE - Irlanda 293
GB - Regno Unito 270
VN - Vietnam 251
HK - Hong Kong 238
FR - Francia 162
CA - Canada 146
FI - Finlandia 125
KR - Corea 99
SE - Svezia 97
JP - Giappone 76
PL - Polonia 66
IN - India 46
AR - Argentina 39
BD - Bangladesh 26
IQ - Iraq 24
MX - Messico 23
UZ - Uzbekistan 22
ZA - Sudafrica 20
NL - Olanda 19
ES - Italia 17
CR - Costa Rica 16
AT - Austria 14
BE - Belgio 13
EC - Ecuador 12
ID - Indonesia 12
PK - Pakistan 11
CL - Cile 10
CZ - Repubblica Ceca 10
AE - Emirati Arabi Uniti 8
PH - Filippine 8
SA - Arabia Saudita 8
CO - Colombia 7
IR - Iran 7
TR - Turchia 7
KG - Kirghizistan 6
PY - Paraguay 6
AU - Australia 5
CH - Svizzera 5
EU - Europa 5
IL - Israele 5
MY - Malesia 5
PE - Perù 5
UY - Uruguay 5
BG - Bulgaria 4
DK - Danimarca 4
EG - Egitto 4
GR - Grecia 4
LT - Lituania 4
NP - Nepal 4
RO - Romania 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DZ - Algeria 3
ET - Etiopia 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
TN - Tunisia 3
TW - Taiwan 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
HU - Ungheria 2
JM - Giamaica 2
NI - Nicaragua 2
OM - Oman 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
GM - Gambi 1
GY - Guiana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 35.078
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.788
Wilmington 7.525
Houston 6.614
Fairfield 814
Ann Arbor 717
Singapore 668
Ashburn 574
Chandler 472
San Jose 349
Seattle 338
Jacksonville 312
Cambridge 275
Dublin 264
Beijing 253
Hong Kong 237
Medford 204
Dearborn 192
Munich 161
New York 151
Rome 130
Mcallen 112
Montréal 110
Santa Clara 108
Lawrence 98
Los Angeles 94
The Dalles 92
Zhengzhou 86
Dallas 82
Ho Chi Minh City 72
Moscow 66
Lauterbourg 64
Tokyo 61
Council Bluffs 58
Helsinki 56
Hanoi 54
Kraków 45
Buffalo 43
San Diego 43
Menlo Park 35
Orem 34
Mülheim 32
São Paulo 31
London 25
Redondo Beach 23
Chicago 21
Frankfurt am Main 20
Milan 19
Kunming 18
Warsaw 17
Denver 16
Johannesburg 16
Norwalk 16
San José 16
Shanghai 16
Falls Church 15
Atlanta 14
Bologna 14
Nanjing 14
Nürnberg 14
San Mateo 14
University Park 14
Brussels 13
Da Nang 13
Guangzhou 13
Haiphong 13
Montreal 13
Nuremberg 13
Rio de Janeiro 13
Chennai 12
Hefei 12
Phoenix 12
Belo Horizonte 11
Saint Petersburg 11
Toronto 11
Boardman 10
Brooklyn 10
Columbus 10
Palo Alto 10
San Francisco 10
Baghdad 9
Seoul 9
Brno 8
Nanchang 8
New Delhi 8
Porto Alegre 8
Verona 8
Washington 8
Dhaka 7
Hounslow 7
Hải Dương 7
Jakarta 7
Mumbai 7
Redmond 7
Redwood City 7
Stockholm 7
Boston 6
Creede 6
Elk Grove Village 6
Fuzhou 6
Mountain View 6
Totale 30.198
Salva come PNG Salva come JPEG
Nome #
Awake thoracoscopic biopsy of anterior mediastinal masses 877
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 574
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 542
Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods 517
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 509
Acute foetal distress and umbilical cord blood banking 497
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 497
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 494
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia 480
A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant 472
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 471
Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors 470
Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. 464
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 462
Cord blood transplantation in adults with acute myeloid leukaemia. 461
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 461
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation 454
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 453
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 447
Placental/Umbilical cord blood: experience of St. Eugenio Hospital collection center 446
The therapeutic use of cord blood 445
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network 442
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 440
Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures 440
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 438
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 437
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 435
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 428
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 423
Algorithm for donor selection in 2011 421
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 421
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 419
Outcomes of allogeneic stem cell transplantation for secondary therapy-related acute myeloid leukaemia 419
Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients 418
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 417
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 416
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies 415
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation 414
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 412
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress 412
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 411
Zoledronic acid-associated thrombotic thrombocytopenic purpura [1] 409
Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission 409
Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma 408
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 408
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 403
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 402
Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. 401
Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors 398
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. 397
BK virus DNA detection by real-time polymerase chain reaction in clinical specimens 395
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 394
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT. 393
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia 390
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 380
Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease 378
Organizzazione e attività delle Banche di sangue placentare 374
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 373
CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA 371
Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders 370
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 369
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 365
Identification of the novel allele, HLA-A*02:653, in an Italian patient 364
Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant 363
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 359
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 357
Impact of HLA mismatch direction on outcome after umbilical cord blood transplantation for hematological malignant disorders: a retrospective eurocord-EBMT analysis. 352
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 351
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 349
Il Trapianto di Cellule Stminali Emopoietiche. 332
Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies 325
Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study 322
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey 313
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 294
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 294
Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia 279
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update 260
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease 260
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 235
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 215
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 188
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia 185
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies 185
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML 184
Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor 173
Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective 171
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 171
Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 168
Is there still a role for autologous stem cell transplantation for the treatment of acute myeloid leukemia? 165
Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation? 158
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 154
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 153
Allelic HLA matching and pair origin are favorable prognostic factors for unrelated hematopoietic stem cell transplantation in neoplastic hematologic diseases: an Italian analysis by the Gruppo italiano trapianto di cellule staminali e terapie cellulari, Italian bone marrow donor registry, and Associazione Italiana di immunogenetica e biologia dei trapianti 108
Incidence of HLA loss in a global multicentric cohort of post-transplantation relapses: results from the Hlaloss Collaborative Study 98
Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation 66
Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation 62
High resolution donor/recipient HLA matching level in unrelated hematopoietic stem cell transplantation and impact on the transplant outcome: the Italian experience on behalf of GITMO, IBMDR and Aibt 59
Permissive HLA-DPB1 mismatch and survival after unrelated donor allogeneic stem cell transplantation for hematological malignancies: a comparative analysis of different immunogenetic models on 422 patients from GITMO and IBMDR 59
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 58
Totale 35.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021254 0 0 0 0 0 0 0 0 0 0 206 48
2021/2022946 29 120 47 38 23 67 68 55 49 96 71 283
2022/20231.205 147 106 56 158 73 287 95 75 111 6 65 26
2023/2024447 49 10 26 8 51 131 37 11 14 3 1 106
2024/20251.951 81 428 177 131 48 98 174 106 189 228 127 164
2025/20263.301 252 207 429 331 335 127 464 356 424 342 34 0
Totale 35.347